Literature DB >> 18814857

Cataract halos: a driving hazard in aging populations. Implication of the Halometer DG test for assessment of intraocular light scatter.

Mark A Babizhayev1, Hayk Minasyan, Stuart P Richer.   

Abstract

OBJECTIVE AND
BACKGROUND: Cataract, regardless of etiology, results in light scatter and subjective glare. Senile cataract is emerging as a crucial factor in driving safely, particularly in night driving and adverse weather conditions. The authors examined this visual impairment using a new Halometer DG test in the eyes of older adult drivers with and without cataract.
METHOD: Examined subjects consisted of n=65 older adults with cataract in one or both eyes and n=72 adult drivers who did not have a cataract in either eye. Subjects were examined for distance high contrast visual acuity (VA) and red/green disability glare (DG) with a new halo generating instrument. Subjects also completed a subjective Driving Habits Questionnaire (DHQ), designed to obtain information about driving during the past year.
RESULTS: DG increased with age of the driver. VA and Halometer DG testing of better and worse eyes prognosticated impairments which significantly affect driving performance. Cataract subjects demonstrated increased Halometer DG scores and were two to four times more likely to report difficulty with driving at night and with challenging driving situations than were cataract-free drivers.
CONCLUSION: DG is a specific cataract-induced functional age-related risk factor of driving difficulty, easily measured by a technician with a new Halometer DG device. APPLICATION: Optometrists and ophthalmologists should incorporate Halometer DG testing in their pre-examination vision testing rooms for patients over age 55, and also perform this test on others who complain about glare. Traffic safety engineers should incorporate automotive optical-microprocessor-aided tests for DG into cars, to alert drivers of mild functional impairments and progressive degrees of DG sensitization.

Entities:  

Mesh:

Year:  2008        PMID: 18814857     DOI: 10.1016/j.apergo.2007.09.003

Source DB:  PubMed          Journal:  Appl Ergon        ISSN: 0003-6870            Impact factor:   3.661


  7 in total

1.  Psychophysical impact and optical and morphological characteristics of symptomatic non-advanced cataract.

Authors:  S Charalampidou; J Nolan; J Loughman; J Stack; G Higgins; L Cassidy; S Beatty
Journal:  Eye (Lond)       Date:  2011-06-10       Impact factor: 3.775

2.  Assessment of dysphotopsia in pseudophakic subjects with multifocal intraocular lenses.

Authors:  Phillip J Buckhurst; Shehzad A Naroo; Leon N Davies; Sunil Shah; Tom Drew; James S Wolffsohn
Journal:  BMJ Open Ophthalmol       Date:  2017-06-19

3.  Impact of Defocus and High-Order Aberrations on Light Disturbance Measurements.

Authors:  A Amorim-de-Sousa; R Macedo-de-Araújo; P Fernandes; A Queirós; J M González-Méijome
Journal:  J Ophthalmol       Date:  2019-01-02       Impact factor: 1.909

4.  Intraocular scattering as a predictor of driving performance in older adults with cataracts.

Authors:  Sonia Ortiz-Peregrina; Carolina Ortiz; Carlos Salas; Miriam Casares-López; Margarita Soler; Rosario G Anera
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

5.  Influence of Vision on Drivers: A Pilot Study.

Authors:  Cristina Alvarez-Peregrina; Clara Martinez-Perez; Cesar Villa-Collar; Miguel Ángel Sánchez-Tena
Journal:  Int J Environ Res Public Health       Date:  2021-11-18       Impact factor: 3.390

6.  A survey of potential and previous cataract-surgery patients: what the ophthalmologist should know.

Authors:  Bonnie An Henderson; Kerry Solomon; Samuel Masket; Richard Potvin; Edward J Holland; Robert Cionni; Helga Sandoval
Journal:  Clin Ophthalmol       Date:  2014-08-25

7.  The effects of light scatter when using a photochromic vs. non-photochromic contact lens.

Authors:  Billy R Hammond; John Buch; Lauren Hacker; Jessica Cannon; Youssef Toubouti; Lisa M Renzi-Hammond
Journal:  J Optom       Date:  2020-04-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.